Welcome to our dedicated page for SUIC Worldwide Holdings SEC filings (Ticker: SUIC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Reading SUIC Worldwide Holdings Ltd. filings can feel like decoding three businesses at once—fintech patents, global supply-chain ventures, and a fast-moving food-franchise empire. If you have ever searched for “SUIC insider trading Form 4 transactions” or tried to locate franchise royalty data hidden deep in the annual report, you know the challenge.
Stock Titan solves that problem. Our AI-powered summaries turn a 300-page document into clear, skimmable insights, so understanding SUIC SEC documents with AI takes minutes, not hours. Need the most recent SUIC quarterly earnings report 10-Q filing or want a real-time alert for SUIC Form 4 insider transactions real-time? They appear on this page seconds after EDGAR posts them. Each filing—10-K, 10-Q, 8-K, DEF 14A—is paired with plain-language explanations that answer common investor questions like “What drives segment revenue?” or “How did executive stock transactions affect float?”
- 10-K / Annual Report: Patent valuations, franchise counts, and cash-flow drivers, delivered as SUIC annual report 10-K simplified.
- 10-Q / Quarterly Report: Margin shifts across fintech and food segments with concise SUIC earnings report filing analysis.
- 8-K: Material partnership updates—SUIC 8-K material events explained the same day they’re filed.
- Form 4: Track every SUIC executive stock transactions Form 4 to spot buying or selling trends.
- Proxy Statement: See SUIC proxy statement executive compensation laid out in straightforward charts.
Whether you want to compare quarter-over-quarter fintech margins or monitor insider sales before a franchising expansion, our platform keeps you current. SUIC SEC filings explained simply—complete coverage, AI clarity, zero guesswork.
SUIC Worldwide Holdings (SUIC) filed its Q3 2025 10‑Q, reporting limited revenue and ongoing losses alongside a going concern warning. The company recorded revenue of $18,482 for the nine months ended September 30, 2025, generating a gross profit of $11,382. Operating expenses were $67,460, and interest expense totaled $17,827, resulting in a nine‑month net loss of $70,898 (vs. $188,694 a year ago). For the quarter, the net loss was $11,221.
Liquidity remains strained. Cash was $7,512 and total assets were $38,743 against total liabilities of $867,960, leading to a stockholders’ deficiency of $(829,218). Current liabilities include short‑term debt $97,710, loan payables‑others $259,445, and accrued expenses $123,734. Long‑term convertible notes are $279,000 (convertible at $0.001 per share). Management disclosed substantial doubt about the company’s ability to continue as a going concern. The company also restated prior revenue to $0 for the comparable 2024 period. Shares outstanding were 11,396,638 as of November 12, 2025.